TCM
AGN

Tekla Capital Management’s Allergan plc AGN Stock Holding History

Tekla Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-157,981
Closed -$28M – 226
2020
Q1 		$28M Sell
157,981
-1,600
-1% -$301K 1.26% 19
2019
Q4 		$30.5M Buy
159,581
+14,300
+10% +$2.58M 1.15% 21
2019
Q3 		$24.4M Buy
145,281
+1,000
+0.7% +$163K 1.07% 25
2019
Q2 		$24.2M Sell
144,281
-48,982
-25% -$6.78M 0.99% 26
2019
Q1 		$28.3M Sell
193,263
-41,457
-18% -$6.01M 1.15% 20
2018
Q4 		$31.4M Sell
234,720
-14,116
-6% -$2.31M 1.34% 20
2018
Q3 		$47.4M Hold
248,836
– – 1.72% 13
2018
Q2 		$41.5M Hold
248,836
– – 1.57% 16
2018
Q1 		$41.9M Buy
248,836
+40,656
+20% +$6.82M 1.63% 18
2017
Q4 		$34.1M Sell
208,180
-130,799
-39% -$23.5M 1.31% 19
2017
Q3 		$69.5M Buy
338,979
+28,369
+9% +$6.6M 2.48% 11
2017
Q2 		$75.5M Hold
310,610
– – 2.8% 11
2017
Q1 		$74.2M Sell
310,610
-123,476
-28% -$28.8M 2.88% 10
2016
Q4 		$91.2M Hold
434,086
– – 3.88% 5
2016
Q3 		$100M Sell
434,086
-29,800
-6% -$7.28M 3.84% 4
2016
Q2 		$107M Buy
463,886
+54,300
+13% +$12.5M 4.38% 4
2016
Q1 		$110M Hold
409,586
– – 4.67% 4
2015
Q4 		$128M Buy
409,586
+91,900
+29% +$27.4M 4.64% 5
2015
Q3 		$86.3M Sell
317,686
-26,000
-8% -$7.99M 3.1% 8
2015
Q2 		$104M Sell
343,686
-18,000
-5% -$5.37M 3.77% 7
2015
Q1 		$108M Buy
361,686
+84,055
+30% +$24M 4.27% 4
2014
Q4 		$71.5M Hold
277,631
– – 3.35% 7
2014
Q3 		$67M Buy
277,631
+71,924
+35% +$16.1M 3.14% 7
2014
Q2 		$45.9M Hold
205,707
– – 4.21% 8
2014
Q1 		$42.3M Hold
205,707
– – 4.23% 7
2013
Q4 		$34.6M Buy
205,707
+114,207
+125% +$17.9M 3.63% 8
2013
Q3 		$13.2M Hold
91,500
– – 1.47% 22
2013
Q2 		$11.5M Buy
+91,500
New +$10.4M 1.57% 20

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Tekla Capital Management's AGN Position: Q2 2020 in Review

Tekla Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 157,981 shares — an estimated $28M sold.

Tekla Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $128M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tekla Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tekla Capital Management sold 157,981 Allergan plc shares in Q2 2020, an estimated $28M.
  • Tekla Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Tekla Capital Management's Allergan plc position peaked at $128M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tekla Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.